08/04/2026 | Press release | Distributed by Public on 08/03/2026 22:13
Memorial Sloan Kettering Cancer Center (MSK) has again been recognized among the nation's very best, earning the distinction as the top cancer center in the Northeast and in the New York metropolitan area, the #2 hospital for cancer care in the country, and the #1 hospital in the nation for urology care in the 2026-27 U.S. News & World Report Best Hospitals rankings. MSK has held its place among the nation's top two cancer hospitals and remained the leading cancer center in the Northeast since the rankings were established more than 35 years ago.
"Being named the top cancer center in the Northeast and New York metropolitan area, and among the nation's leading cancer hospitals, is both an honor and a responsibility," said Selwyn M. Vickers, MD, FACS, President and CEO of MSK. "This recognition reflects the extraordinary people of MSK. Every day, our physicians, researchers, nurses, and staff advance cancer care with one goal in mind: improving the lives of patients and families. Together, we are working to end cancer for life."
This latest recognition comes during a remarkable period of innovation and achievement. Over the past year, MSK earned national and global recognition for excellence in patient care, nursing, innovation, and workplace culture. In 2025, the U.S. Food and Drug Administration (FDA) approved 10 drugs based on clinical trials in which MSK played a pivotal role. Additionally, MSK earned its third Magnet® designation for nursing excellence and received Press Ganey's Guardian of Excellence Award for patient experience. MSK was also recognized by Forbes for the eighth consecutive year as one of America's Best Large Employers and as the nation's top cancer center to work for, and it was named one of Fast Company's Top 10 Best Workplaces for Innovators.
For the fourth consecutive year, MSK secured USNWR's #1 national ranking in urology care, underscoring its leadership in the field. MSK's multidisciplinary urology team brings together experts in surgery, medical oncology, radiation oncology, radiology, pathology, and nursing to deliver highly personalized care while advancing innovative treatments that improve outcomes and preserve quality of life.
In addition, MSK's gastroenterology and GI surgery services were ranked #25.
The U.S. News & World Report rankings evaluate hospitals using a range of measures, including clinical outcomes, patient safety, nursing excellence, and reputation among board-certified physician specialists. Together, these honors underscore MSK's long-standing leadership in transforming cancer care and advancing hope for patients around the world.
MEDIA CONTACT:
Rebecca Williams
[email protected]